FECHF yields 3.47% · MRK yields 2.81%● Live data
📍 MRK pulled ahead of the other in Year 1
Combined, FECHF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of FECHF + MRK for your $10,000?
Fidelity China Special Situations PLC is a close-ended equity mutual fund launched and managed by FIL Investment Services (UK) Limited. The fund is co-managed by FIL Investment Management (Hong Kong) Limited and FIL Investments International. It invests in the public equity markets of China, which includes companies listed in China or Hong Kong and Chinese companies on other stock exchanges. The fund seeks to invest in stocks of companies operating across diversified sectors. It primarily invests in growth stocks of companies. The fund also invests in derivative instruments. It conducts in-house research to make its investments. The fund benchmarks the performance of its portfolio against the MSCI China Index. Fidelity China Special Situations PLC was formed on January 22, 2010 and is domiciled in the United Kingdom.
Full FECHF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.